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Abstract: Purple urine bag syndrome (PUBS) is a rare occurrence, in which the patient has a 
purple-colored urine bag following urinary catheterization for hours to days. Most of authors 
believe it is a mixture of indigo (blue) and indirubin (red) that becomes purple. Previous study 
showed that PUBS occurred predominantly in chronically catheterized, constipated women. 
We collected 10 elderly patients with PUBS in two nursing homes. The ﬁ  rst two cases were 
identiﬁ  ed by chart review in 1987 and 2003, and then later eight cases (42.1%) were collected 
among 19 urinary catheterized elderly in the period between January 2007 and June 2007. In 
the present report, PUBS probably can occur in any patients with the right elements, namely 
urinary tract infection (UTI) with bacteria possessing these enzymes, diet with enough tryp-
tophan, and being catheterized. Associations with bed-bound state, Alzheimer’s, or dementia 
from other causes are reﬂ  ections of the state of such patients who are at higher risk for UTI, and 
hence PUBS occurred. Although we presented PUBS as a harmless problem, prevention and 
control of the nosocomial catheter-associated UTIs (CAUTIs) has become very important in 
the new patient-centered medical era. Thus, we should decrease the duration of catheterization, 
improve catheter care, and deploy technological advances designed for prevention, especially 
in the elderly cared for in nursing homes.
Keyword: purple urine bag syndrome, indigo, indirubin, nursing home, bacteriuria, indoxyl 
sulphatase/phosphatase, nosocomial catheter-associated UTIs
Introduction
Purple urine bag syndrome (PUBS) was ﬁ  rst reported in 1978 (Barlow and Dickson 
1978). The patient had a purple-colored urine bag following urinary catheterization 
for hours to days (Stott et al 1978; Dealler et al 1988; Al-Jubouri and Vardhan 2001; 
Lin et al 2002). Although the deﬁ  nite chemical substrate of PUBS is unknown, most 
authors believe it is a mixture of indigo (blue) and indirubin (red) that becomes purple 
(Dealler et al 1988; Matsuo et al 1993; Umeki 1993; Nakayama and Kanmatsuse 1997; 
Ishiha et al 1999; Al-Jubouri and Vardhan 2001; Ribeiro et al 2004). The chain reaction 
responsible for PUBS began with tryptophan from the food chain being metabolized 
by gut bacteria. This metabolic process produces indole, which is absorbed into portal 
circulation and converted to indoxyl sulphate in the liver, after a series of detoxiﬁ  cation 
transformations (Figure 1) (Chiou et al 2005).
Case report
In this study, we collected 10 elderly patients with PUBS cared for by the senior regis-
tered nurses at two nursing homes in southern Taiwan community hospitals (Table 1). 
Case 1 and case 2 who were identiﬁ  ed by chart review in 1987 and 2003, respectively, 
and the latter 8 cases (3 males, 5 females) were collected between January 2007 and 
June 2007. The two nursing home had 74 residents (52 males, 22 females), of which 
19 (8 males, 11 females) had undergone Foley catheterization. The incidence of PUBS Clinical Interventions in Aging 2008:3(4) 730
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was 42.1% among the 19 urinary catheterized nursing home 
residents in the follow-up half-year period.
Case 1, a 72-year-old male with PUBS, was found in 
1987. He was a patient with type 2 diabetes mellitus (DM), 
diabetic nephropathy (DN), and end-stage renal disease 
(ESRD), treated with hemodialysis for 3 years. He was lost 
to follow-up after being transferred to a medical hospital 
due to a medical illness in 1990. PUBS had been observed 
off and on for 3 years.
Case 2, a 72-year-old male, was a patient with type 2 DM, 
diabetic nephropathy, and ESRD, treated with hemodialysis. 
PUBS had persisted off and on for 3 years, beginning in 
November 2000. He expired because he refused hemodialysis 
in 2003. PUBS had been noted off and on for one year.
Case 3, an 83-year-old male, had had DM for about 15 
years, Alzheimer’s dementia (AD) for 2 years, and hyperten-
sion treated with amlodipine besylate (Norvasc®) 5 mg per 
day for about 10 years. He had received Foley catheterization 
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due to neurological bladder for more than 26 months. The 
patient had a purple-colored urine bag 2–3 days following 
urinary catheterization or changing of the Foley off and on 
for more than 24 months (Figure 2).
Case 4, an 89-year-old male, had been a patient with 
DM and diabetic nephropathy for 40 years, ESRD treated 
with hemodialysis for 20 years, Alzheimer’s dementia for 
about 5 years, and hypertension treated with furosemide 
(Lasix®) 40 mg per day for 20 years. He underwent Foley 
catheterization due to benign prostate hypertrophy (BPH) and 
had suffered from PUBS off and on for more than 33 months, 
before being transferred to this nursing home (Figure 3).
Case 5, an 80-year-old male, had been a patient with 
vascular dementia (VaD) with delirium since 2 years ago. He 
had also suffered from hypertension and BPH for 20 years. 
He became long-term bedridden because of fracture of the left 
femoral neck about 3 years ago. He suffered from PUBS off 
and on for 10 months. He regularly took doxazosin mesylate 
(Doxaben®) 1 mg per day for hypertension and BPH, and 
quetiapine fumarate (Seroquel®) 100 mg per day for vascular 
dementia with delirium.
Case 6, an 80-year-old female, was a patient with 
Alzheimer’s dementia, anemia, hepatitis, hypercholes-
trolemia and pulmonary ﬁ  brosis. She became long-term 
bedridden since 5 years ago. She suffered from PUBS off and 
on for 2 years. She did not take any drugs regularly.
Case 7, a 76-year-old female, had been a patient with 
VaD and anemia since 10 years ago. She had received Foley 
catheterization for 6 years. PUBS had been noted off and on 
for 2 years. She did not take any drugs.
Case 8, a 66-year-old female, was a patient with 
hypertension, hypercholesterolemia, and VaD with delirium. 
She took amlodipine besylate (Norvasc®) 10 mg per day 
for hypertension, and Melitracen 10 mg/Flupentixol 0.5 mg 
(Deanxit®) 1 tab per night for VaD with delirium. She became 
long-term bedridden and received Foley catheterization for 4 years 
after a stroke. PUBS had been noted off and on for 16 months.
Case 9, a 60-year-old female, was a patient with 
schizophrenia and poliomyelitis. She became long-term bed-
ridden and received Foley catheterization for 5 years. PUBS 
had been noted off and on for 4 years. She regularly took 
Melitracen 10 mg/Flupentixol 0.5 mg (Deanxit®) 2 tab per 
night and lorazepam (Ativan®) 0.5 mg per night.
Figure 2 The urinary catheter drainage system with changing color from red to 
purple and sometimes with differently colored tube and bag in case 3 with purple 
urine bag syndrome.
Figure 3 The longer the PVC bag stayed in use for a patient, the deeper the color 
purple the bag became, despite changing sterile PVC urine bags from 2 different 
companies.Clinical Interventions in Aging 2008:3(4) 733
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Case 10, a 75-year-old female, had been a patient with 
DM, hypertension, VaD, and hypercholestrolemia for 6 years. 
She had taken glipizide (Minidiab®) 5 mg per day for DM, and 
nifedipine (Adalat OROS®) 30 mg per day for hypertension. 
She had been long-term bedridden for 6 years after a stroke, 
and had received Foley catheterization for 1 year. PUBS had 
been noted for 3 months.
The mean age of the 10 elderly patients (5 males, 5 females) 
was 75.30 years (SD 8.39, range 60–89). They were long-
term bedridden for an average of 4.45 years (SD 2.43, range 
1.5–10), and received urinary catheterization for an aver-
age of 35.9 months (SD 18.66, range 12–72). Only about 
30.0% of the patients had had long-term constipation. Their 
vital signs were all stable even though their urine routine 
showed urinary tract infection (UTI). Among the ten cases, 
9 (90.0%) had dementia; 80% of the male cases also had 
diagnoses of DM, diabetic nephropathy, and ESRD with 
hemodialysis. Therefore PUBS had a higher incidence in 
patients with chronic disease such as dementia, diabetic 
nephropathy, a long-term bedridden state, and long-term 
Foley catheterization.
The later 8 cases received further laboratory examinations. 
They had purple, crystalline, and alkaline urine (PH 8.0∼9.0). 
Escherichia coli, Klebsiella Pneumoniae, Providencia 
rettegeri, and Proteus mirabilis were revealed in their urine 
culture. Their blood routine showed white blood cells, 
3800∼8300/μL, and Hb, 8.6∼14.1 g/dL. Seven cases (87.5%) 
had mild anemia. In the biochemistry examinations, seven 
cases (87.5%) revealed normal renal functioning, except case 
4 with diabetic nephropathy with ESRD. Three cases (37.5%) 
had hypercholestrolemia. Two cases (25%) had hepatitis. 
All patients had stable vital signs, and had no infection sign 
such as leukocytosis, fever, or chill was found, even though 
PUBS and bacteriuria persisted. All patients did not receive 
any antibiotics treatment. We decreased their duration of 
catheterization, replaced their Foley and urine bag regularly, 
and improved their quality of catheter care. Then PUBS did 
not occur again.
Discussion
PUBS is rarely reported: only one larger survey study among 
the 23 papers regarding PUBS published since 1987 was 
found in a PubMed search. Although the exact prevalence 
of PUBS is unknown, but it may not be rare because the 
prevalence of PUBS was found to be 9.8% (seven of 71) 
in the study of Dealler and colleagues (1988) and 8.3% 
(13 of 157) at a long-term care service center in a Taiwan 
community hospital (Su et al 2005). In this report, the 
prevalence of PUBS was as high as 42.1% (eight of 19) 
in urinary catheterized nursing home residents. Why the 
prevalence of PUBS was so high in this report? We need a 
larger study for further evaluation of PUBS in Taiwan nurs-
ing home in the future.
A previous study showed that PUBS occurred predomi-
nantly in chronically catheterized, constipated women (Su 
et al 2005). No previous positive association study between 
PUBS and medications, such as Norvasc®, Lasix®, Doxaben®, 
Adalat OROS®, Minidiab®, Seroquel®, Deanxit®, or Stilnox® 
has been reported before. PUBS was found to be associated 
with alkaline urine as well as UTI induced by some species 
of bacteria with indoxyl sulphatase/phosphatase (Ribeiro et al 
2004). But in this report, the four cases at the ﬁ  rst nursing 
home were all male and were nursing home residents since 
1987. They also did not have long-term constipation or diar-
rhea. Female gender or constipation was possibly not the 
absolute criteria of PUBS. This is similar to the viewpoint 
of Lin and colleagues (2002).
In urine culture, several bacterial species have been 
reported in association with PUBS including Providen-
cia stuartii, P. rettgeri, K. pneumoniae, P. mirabilis, 
E. coli, Morganella morganii, and Pseudomonas aerugi-
nosa (Dealler et al 1988; Matsuo et al 1993; Umeki 1993; 
Nobukuni et al 1995; Ishiha et al 1999; Al-Jubouri et al 2001; 
Lin et al 2002; Zotti et al 2004). Our urine culture results were 
similar to those of previous reports, and revealing E. coli, 
K. pneumoniae, P. rettegeri, and P. mirabilis.
P. mirabilis compromises the care of many patients 
undergoing long-term indwelling bladder catheterization. 
In a prevalence study of hospital-acquired infections (HAI), 
a signiﬁ  cant correlation was found with major risk factors 
related to medical procedures, such as urinary catheteriza-
tion (Zotti et al 2004). A failure to decrease the unnecessary 
bladder catheter use and the duration of catheterization 
would result in poor quality of care (Landi et al 2004), a 
greater mean length of stay in hospital, and a higher risk of 
nosocomial UTI (Zotti et al 2004).
It was apparent that PUBS affected not only the urine 
bags but also indwelling catheters. The urinary catheter 
drainage system changed color from red to purple and some-
times showed differently colored tubes and bags, as in case 
3 with PUBS (Figure 2). We found that the longer the PVC 
bag stayed in use for a patient, the deeper the color purple 
the bag became, despite changing sterile PVC urine bags 
from 2 different companies, which was compatible with 
the ﬁ  ndings of Dealler and colleagues (1988) and Su and 
colleagues (2005).Clinical Interventions in Aging 2008:3(4) 734
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Conclusion
In conclusion, the pigments associated with PUBS have been 
well shown to be due to indirubin and indigo. The patho-
genesis of PUBS is due to the metabolism of tryptophan by 
bacteria to indole and later converted to indicant in the liver 
(Dealler et al 1988). This is excreted and in the urine broken 
down by bacteria possessing one or both enzymes, sulphatase 
and phosphatase that metabolize this pigment to indirubin 
and indigo in an alkaline environment (urine). The indigo 
can also be precipitate in the catheter itself giving a blue 
discoloration (Harun et al 2007). In this paper, we found that 
PUBS seemed to have a higher incidence in patients with a 
bedridden status, alkaline urine, and species of bacteria with 
indoxyl sulphatase/phosphatase, but possibly not associated 
with gender, constipation, or type of PVC urine bag used. 
We also presented that PUBS was a harmless, but alarming 
problem (Robinson 2003). It is unnecessary to aggressively 
treat patients with PUBS, but the control of urological sanita-
tion is fundamental to treatment.
In Taiwan, geriatric medicine, nursing home care, and 
HAI control have become very important because nosocomial 
catheter-associated UTIs comprise a huge silent reservoir of 
antibiotic-resistant bacteria and yeasts (Tambyah and Maki 
2000; Robinson 2003; Hampton 2004). Thus, we should 
decrease the duration of catheterization, improve catheter care, 
and deploy technological advances designed for prevention.
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